TKG Huchems Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St

March 19, 2025

TKG Huchems (KRX:069260) Full Year 2024 Results

Key Financial Results

Revenue: ₩1.19t (up 13% from FY 2023).
Net income: ₩77.7b (down 42% from FY 2023).
Profit margin: 6.5% (down from 13% in FY 2023). The decrease in margin was driven by higher expenses.
EPS: ₩2,024 (down from ₩3,512 in FY 2023).

earnings-and-revenue-growth — KOSE:A069260 Earnings and Revenue Growth March 19th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

TKG Huchems Revenues Beat Expectations

Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) was mostly in line with analyst estimates.

Looking ahead, revenue is forecast to grow 5.6% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in South Korea.

Performance of the South Korean Chemicals industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

We should say that we've discovered 2 warning signs for TKG Huchems that you should be aware of before investing here.

If you're looking to trade TKG Huchems, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Valuation is complex, but we're here to simplify it.

Discover if TKG Huchems might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.